REQUEST A DEMO
Total
USD $0.00
Search more companies

Qurient Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Nanotechnology
Full name: Qurient Co., Ltd. Profile Updated: July 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Qurient Co., Ltd is a biotech company that specializes in a unique virtual biotech model called 'Network R&D' that covers both clinical development and early discovery research stages. Qurient focuses on value creation between early discovery to clinical proof-of-concept and aims to provide innovation for unmet medical needs.

Headquarters
8F, C Dong, 242, Pangyo-Ro, Bundang-Gu
Seongnam; Gyeonggi; Postal Code: 13487

Contact Details: Purchase the Qurient Co., Ltd. report to view the information.

Website: http://www.qurient.com

Basic Information
Total Employees:
Purchase the Qurient Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Qurient Co., Ltd. report to view the information.
Registered Capital:
Purchase the Qurient Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Qurient Co., Ltd. report to view the information.
Incorporation Date:
July 02, 2008
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
11.4%
Purchase this report to view the information.
8.3%
Purchase this report to view the information.
2.4%
Subsidiaries
Qli5 Therapeutics Gmbh
Company Performance
Financial values in the chart are available after Qurient Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-14.22%
Total Operating Revenue
-13.96%
Operating Profit
-4.09%
EBITDA
-3.88%
Net Profit/Loss for the Period
-3.29%
Total Assets
1.05%
Total Equity
-31.92%
Operating Profit Margin
-65.92%
Net Profit Margin
-59.69%
Return on Equity (ROE)
-20.78%
Debt / Equity
-567%
Quick Ratio
-13166.47%
Cash Ratio
-6.53%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?